Rigel Announces Publication of Data on REZLIDHIA® (Olut

/PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced a peer-reviewed publication in Leukemia & Lymphoma on data from an analysis of the...

Related Keywords

United States , South San Francisco , California , Georgia , American , David Rosen , Jorgee Cortes , Raul Rodriguez , Cecilf Whitaker Jr , Rigel Pharmaceuticals Inc , American Cancer Society , European Medicines Agency , Exchange Commission , Georgia Cancer Center , Prnewswire Rigel Pharmaceuticals Inc , Nasdaq , Scholar Chair , Full Prescribing Information , Rigel Pharmaceuticals , American Cancer , Key Statistics , Acute Myeloid Leukemia , Revised January , Acute Myeloid Leukaemia , Post Venetoclax Patients , Annual Report , Nc ,